AstraZeneca

AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company headquartered in Cambridge, England, on the Cambridge Biomedical Campus. Its product portfolio includes treatments for important disorders in cancer, cardiology, gastrointestinal, infection, neurology, respiratory, and inflammation. It was involved in the development of the Oxford-AstraZeneca COVID-19 vaccine.

In 1999, the Swedish Astra AB and the British Zeneca Group merged to form the firm. Since the merger, it has been one of the world's largest pharmaceutical businesses, acquiring Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013), and Definiens (by MedImmune in 2014). It concentrates its research and development in three strategic locations: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, USA.

AstraZeneca is a worldwide pharmaceutical corporation focused on patients and led by research. It is committed to shaping the future of healthcare by using the power of science to benefit people, society, and the world. AstraZeneca is committed to developing truly revolutionary medicines and increasing access to them in order to benefit patients, healthcare systems, and society worldwide. Its aim for patients is to provide the healthcare experience and outcomes that people value the most, allowing them to live fulfilling lives. AstraZeneca's mission is to improve the lives of those suffering from disease and illness.

Founded: 1999
Headquarters: Cambridge, England, UK
Website: https://www.astrazeneca.com/